We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Foxtons Group Plc | LSE:FOXT | London | Ordinary Share | GB00BCKFY513 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 1.00 | 1.83% | 55.60 | 55.00 | 56.00 | 55.00 | 53.00 | 53.00 | 292,844 | 16:35:29 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Real Estate Agents & Mgrs | 147.13M | 5.49M | 0.0182 | 30.22 | 165.71M |
From Apr 2019 to Apr 2024
TIDMFOXT
RNS Number : 8396V
Foxtons Group PLC
05 December 2019
Foxtons Group plc
("Foxtons" or the "Company")
Director Declaration
The Company announces that Garry Watts, Non-Executive Chairman of the Company, will be appointed as a non-executive director and senior independent director of Circassia Pharmaceuticals plc, a company listed on AlM, with effect from 2 March 2020.
This announcement is made in accordance with Listing Rule 9.6.14.
5 December 2019
For further information please contact:
Hot Features
Premium
Foxtons Group plc
Chris Hough, Company Secretary
Muhammed Patel, Investor Relations +44 20 7893 6261
-----------------
LEI: 5493001HCMG6R1MYKC59
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
RDNGMMGZMKNGLZM
(END) Dow Jones Newswires
December 05, 2019 06:09 ET (11:09 GMT)
1 Year Foxtons Chart |
1 Month Foxtons Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
